Navigation Links
World Antibiotic Resistance Market Saw Big Changes in Last Five Years, According to Biopharm Reports Study Available at

London, UK (PRWEB) August 27, 2013

Threats caused by the worldwide upsurge in antibiotic resistant bacterial strains keep on triggering concern. In the United States, around 60% of all hospital-acquired infections are induced by antibiotic resistant bacteria. Thus, in 2009, 440,000 new cases of multidrug-resistant tuberculosis (MDR TB) were registered in 69 countries of the world. In Europe alone, 25,000 people died from drug-resistant infections in the same year. Despite an increase in the usage of antibiotics in recent decades, the approval of new antibiotics in the United States fell 60% to just 12 during 1998-2009 as compared to the decade 1983-1992. Despite a remarkable increase in the number and novelty of new pipeline antibiotics in the recent past, the health threats posed by antibiotic resistance need to be tackled in many different ways, without delay.

The last five years have seen major changes in practices, innovation and attitudes in answer to these looming threats. These are driving innovation in drug discovery and diagnostics, as well as in clinical practices and the ways in which antibiotics are being used. In an effort to ensure the most effective and appropriate use of antibiotics, there is increasing surveillance, both local and international, to monitor the emergence and expansion of antibiotic resistant strains. These developments offer fresh opportunities for the developers in drug discovery and in diagnostics fields.

Updated research report “Antibiotic Resistance 2013: A Global Market Study” worked out by Biopharm Reports has been recently published by Market Publishers Ltd.

Report Details:

Title: Antibiotic Resistance 2013: A Global Market Study
Published: February, 2013
Pages: 176
Price: US$ 3,496.00

The report carries out a competitive market analysis of current practices and future developments across 25 key areas relating to antibiotic resistance. It identifies the changes that are taking place in the antibiotic resistance market, and highlights the opportunities these present to developers in each of the market areas - diagnostics, clinical, and laboratory. The study provides a comprehensive overview of current and evolving practices, developments and strategies and their importance in coping with, and managing antibiotic resistance. The research is supplemented with a wealth of information on companies and government bodies working in the field. It also identifies commercial opportunities in the market and gives insights designed to enhance decision-making in this challenging marketplace.

Reasons to Buy:

  •     Gain valuable insights into various marketing and sales opportunities;
  •     Understand the purchasing decisions taken by clinicians and scientists;
  •     Be equipped with valuable knowledge of market growth and shrinkage;
  •     Keep watch over innovation and new product opportunities for the global suppliers in each of the market areas - diagnostics, clinical, and laboratory.
More updated and new research reports by Biopharm Reports can be found at

About Us: is a multilingual hypermarket offering a rich collection of comprehensive studies on various markets, sectors, industries, companies, etc. We perform professional services aimed to equip our clients with high-quality research products and support critical decision-making.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Table Salt Production in the US Industry Market Research Report Now Available from IBISWorld
2. THE SIGNATURE GROUP Achieves Cisco Cloud and Managed Services Master Channel Partner Worldwide - Second Year Running
3. Global Compression Therapy Market to 2019: Worldwide Industry Latest Market Share, Strategy, Growth, Size, Trends And Forecast Research Report 2019
4. Worldwide Power Products Expands Rental Product Line to Include Natural Gas Engines, Helps Operators in Rural Locations Secure Continuous Power
5. WorldCom Online Marketing Partners with Flagship One
6. Online Eyeglasses and Contact Lens Sales in the US Industry Market Research Report Now Available from IBISWorld
7. China Human Vaccine Industry Outlook 2012-2015: Worldwide Industry Latest Market Share, Strategy, Growth, Size, Trends And Forecast Research Report
8. The Holistic Sanctuary Highlights the Dangers of Conventional Drug Rehab: US News & World Report Reveals Links Between Heroin Addiction and Prescription Medications
9. Laboratory Supply Wholesaling in Canada Industry Market Research Report Now Available from IBISWorld
10. Worldwide Power Products Breaks into the Inc. 500
11. Ice Cream Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld
Post Your Comments:
(Date:12/1/2015)... ... 2015 , ... Speech and physical therapies are traditionally conducted ... and under the right circumstances, these practices can be merged. This combination ... his or her therapeutic sessions, as well as gives the physical and speech ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... Libertyville, IL (PRWEB) , ... December 01, 2015 ... ... catheters, keeping their independence is everything. That is why Hollister Incorporated has launched ... excited to offer this next product in the VaPro touch free catheter portfolio,” ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of ... latest addition to the devices for sale in the United States. Clarity is ... long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy to own ...
(Date:12/1/2015)... , ... December 01, 2015 , ... With FCPX ... and with full control over customization, the possibilities are truly endless, all with a ... randomization, overlay depth position, vertical flip, horizontal flip, depth of field and more, all ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel ... the company will present at the LD Micro Main Event. ... Sunset Boulevard Hotel in Los Angeles, CA. ... present on Thursday, December 3, at 9:00 am Pacific time ... at least 10 minutes prior to the start of the ...
(Date:12/1/2015)... Dec. 1, 2015   MabVax Therapeutics Holdings, Inc ... announces it has filed an Investigational New Drug Application ... for the Company,s lead fully human antibody product HuMab ... MabVax plans to initiate the Phase I clinical trial ... --> The planned Phase I trial will ...
(Date:12/1/2015)... 2015   Craneware, Inc ., the healthcare ... announced the company will showcase a new version ... solution at the American Society for Health-System ... The new features are focused on simplifying and ... managing enterprise-wide pharmacy charges to ensure compliance and ...
Breaking Medicine Technology: